The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE
Coronavirus: Hong Kong panel recommends Pfizer-BioNTech vaccine for use, but seeks more information over Norway deaths
- Unanimous backing from experts will go before health secretary for final decision, paving way for mass inoculation drive from mid-February
- Panel chairman says Pfizer-BioNTech vaccine’s benefits outweigh risks, but adds it will request more information from Norway on deaths there
The Covid-19 vaccine co-developed by Pfizer has sought emergency-use approval in Hong Kong. Photo: EPA-EFE